Active Ingredient: RIPRETINIB
Proprietary Name: QINLOCK
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 50MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N213973
Product Number: 001
Approval Date: May 15, 2020
Applicant Holder Full Name: DECIPHERA PHARMACEUTICALS LLC
Marketing Status:
Prescription
Patent and Exclusivity Information
